Associate Director, Pharmacovigilance Operations

Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. The Axsome team is a lean, dynamic group of individuals committed to addressing unmet needs for patients with CNS disorders. Axsome is based in New York City.About This Role Axsome Therapeutics is seeking an Associate Director, Pharmacovigilance (PV) Operations to manage individual case safety reports (ICSRs) from receipt of source documents and appropriate submissions to relevant Health Authorities globally. The Associate Director, PV Operations is responsible for oversight of the case processing activities of PV Service Providers, ensuring timely expedited submission of ICSRs to relevant Health Authorities, developing relevant key performance indicators for compliance monitoring, and ensuring robust and efficient case processing systems. The Associate Director, PV Operations will report directly to the Senior Director, PV Operations and will work cross-functionally with different departments, including Clinical Development, Medical Information, Medical Affairs, Quality, Regulatory and Legal, as well as multiple external Service Providers. This role is based at Axsome's HQ in New York City with an on-site requirement of at least three days per week. We are unable to consider candidates who are looking for fully remote roles. Job Responsibilities and Duties include, but are not limited to, the following: Oversee the vendor case processing activities to ensure the quality of safety cases Perform both real-time and retrospective quality control of safety case data entry to ensure quality and compliance with the data entry conventions and MedDRAWHO DD coding conventionsTrend the case quality of both investigational and approved products and communicate to the case processing vendorDevelop and review Quality Control reports to identify trends in ICSR related criteria, such as invalid cases, spot data entry errorsEnsure ICSR reconciliations are performed with the relevant parties in a timely mannerParticipate the vendor quality meetings and governance meetings Oversee the vendor case processing activities to ensure compliance with regulatory submissions and internal timelines including monitoring the workflow status of safety cases and or the pending regulatory submissions of ICSRsAnalyze and investigate for late forwarding, data entry, submissiondistribution of safety reports, as applicableSupport the authoring or review the periodic safety reports to ensure timely submissionsPerform and oversee reconciliations with internalexternal stakeholders to ensure cases are exchanged as per the relevant agreementProvide input on behalf of PV Operations on individual study-specific documents including but, but not limited to, Safety Operational Management Plan, SAE Reconciliation Plan, Data Validation Plan, and Safety Reporting Form Specifications DocumentSupport the set-up and maintenance of individual study-specific activities, including, but not limited to Market Research Projects, Patient Support Programs, Patient Assistance Program, Clinical Trials, etc. Support and provide guidance on questions concerning PV Operations based on, not only company conventions, but also regulatory guidance from Health AuthoritiesContribute to the creation or updating of Standard Operating Procedures, Working Instructions, and training materials concerning safety case processing and operations Support Axsome initiatives and projects representing PV Operations Requirements Qualifications Bachelor's degree required. A Master's degree in Science, or other Health Care Professional degree preferred i.e., MSn, RN, PharmD 8+ years of experience in Pharmacovigilance Operations Extensive experience in case processing, regulatory requirements of ICSRs, MedDRA, WHODD, project management Knowledge of ICH E2B(R2) and (R3) specifications and entry guidanceKnowledge of global pharmacovigilance reporting rules and timelines, including but not limited to Health Canada, FDA and EMAAbility to interpret health and medical records such as adverse event reporting forms, a discharge summary, etc.Ability to work on site Monday, Tuesday & Thursday. We are unable to consider candidates who are looking for fully remote roles. Experience and Knowledge Some experience in signal detectionExperience with clinical andor post-marketing case processing, including medical terminologies, MedDRA and WHO DD coding and narrative writingExperience with safety database; ARISg is a plus but not mandatoryExperience with EDC for clinical trial data collection is a plus but not mandatoryExcellent in detailed-oriented tasksSalary & Benefits The anticipated salary range for this role is $170,000 - $195,000. We encourage candidates of all levels to apply as there may be flexibility on final job title and responsibilities. The salary offer will be based on a variety of factors, including experience, qualifications, internal equity and location. Axsome offers a competitive employment package that includes an annual bonus, significant equity and a generous benefits package. Axsome is committed to equal employment opportunity and providing reasonable accommodations to applicants with physical andor mental disabilities. We value and encourage diversity and solicit applications from all qualified applicants without regard to race, color, gender, sex, age, religion, creed, national origin, sexual orientation, gender identity, ancestry, citizenship, marital status, physical or mental disability, medical condition, veteran status, genetic information, or any other characteristic protected by federal, state, or local law.Axsome Therapeutics does not accept unsolicited resumes from recruiters or third-party recruitment agencies and will not pay placement fees for unsolicited candidates that are sent to hiring managers, the HR team or other Axsome team members. Only approved vendors who have been explicitly asked to support a specific search will receive access to our Applicant Tracking System to submit candidates for consideration.

Created: 2025-03-01